Europe has a much larger population compared to the USA and Canada combined, yet its growth levels are seen as lagging. Germany accounts for 0.1% of the overall population that is accessing MMJ through their healthcare system, but other nations still don’t allow medical use of cannabis. Another reason why Europe continues to lag behind is that it still doesn’t enjoy the same political and cultural synchronicity of laws, which Canadian provinces and American states have. Most public majorities already favor the legalization of medical cannabis but this isn’t reflected in the political arena which is necessary to handle the issue.
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and…
This November gathering will bring psychedelic education into conversation with music, visual art, comedy, philosophy,…
Ten p.m. on a Glendale balcony, two floors above the theater that just screened the…
We analyzed seven different 2026 rankings to find the true top 10 cannabis strains in…
A land-rooted look at the growers reshaping cannabis through living soil, ecological intelligence and regenerative…